128 related articles for article (PubMed ID: 35764155)
1. Genetic variants of antioxidant enzymes and environmental exposures as molecular biomarkers associated with the risk and aggressiveness of bladder cancer.
Martin-Way D; Puche-Sanz I; Cozar JM; Zafra-Gomez A; Gomez-Regalado MDC; Morales-Alvarez CM; Hernandez AF; Martinez-Gonzalez LJ; Alvarez-Cubero MJ
Sci Total Environ; 2022 Oct; 843():156965. PubMed ID: 35764155
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in xenobiotic detoxification enzymes, antioxidant defenses and hormonal pathways as biomarkers of susceptibility to prostate cancer.
Martinez-Gonzalez LJ; Antúnez-Rodríguez A; Vazquez-Alonso F; Hernandez AF; Alvarez-Cubero MJ
Sci Total Environ; 2020 Aug; 730():138314. PubMed ID: 32388358
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants of antioxidant and xenobiotic metabolizing enzymes and their association with prostate cancer: A meta-analysis and functional in silico analysis.
Álvarez-González B; Porras-Quesada P; Arenas-Rodríguez V; Tamayo-Gómez A; Vázquez-Alonso F; Martínez-González LJ; Hernández AF; Álvarez-Cubero MJ
Sci Total Environ; 2023 Nov; 898():165530. PubMed ID: 37453710
[TBL] [Abstract][Full Text] [Related]
4. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
Sugawara S; Yamada Y; Arai T; Okato A; Idichi T; Kato M; Koshizuka K; Ichikawa T; Seki N
J Hum Genet; 2018 May; 63(5):657-668. PubMed ID: 29540855
[TBL] [Abstract][Full Text] [Related]
5. Impact of oxidative stress SNPs and dietary antioxidant quality score on prostate cancer.
Pascual-Geler M; Robles-Fernandez I; Monteagudo C; Lopez-Guarnido O; Rodrigo L; Gálvez-Ontiveros Y; Cozar JM; Rivas A; Alvarez-Cubero MJ
Int J Food Sci Nutr; 2020 Jun; 71(4):500-508. PubMed ID: 31647334
[No Abstract] [Full Text] [Related]
6. Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer.
Lin H; Shi X; Li H; Hui J; Liu R; Chen Z; Lu Y; Tan W
BMC Cancer; 2021 Dec; 21(1):1293. PubMed ID: 34861847
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
8. Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness.
Matsushita R; Yoshino H; Enokida H; Goto Y; Miyamoto K; Yonemori M; Inoguchi S; Nakagawa M; Seki N
Oncotarget; 2016 May; 7(19):28460-87. PubMed ID: 27072587
[TBL] [Abstract][Full Text] [Related]
9. Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer.
El-Shal AS; Shalaby SM; Abouhashem SE; Elbary EHA; Azazy S; Rashad NM; Sarhan W
Mol Biol Rep; 2021 May; 48(5):4361-4371. PubMed ID: 34085193
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic panel of serum miR-125b-5p, miR-182-5p, and miR-200c-3p as non-invasive biomarkers for urothelial bladder cancer.
Wen Z; Huang G; Lai Y; Xiao L; Peng X; Liu K; Zhang C; Chen X; Li R; Li X; Lai Y; Ni L
Clin Transl Oncol; 2022 May; 24(5):909-918. PubMed ID: 35028929
[TBL] [Abstract][Full Text] [Related]
11. Co-exposure to metals and polycyclic aromatic hydrocarbons, microRNA expression, and early health damage in coke oven workers.
Deng Q; Dai X; Feng W; Huang S; Yuan Y; Xiao Y; Zhang Z; Deng N; Deng H; Zhang X; Kuang D; Li X; Zhang W; Zhang X; Guo H; Wu T
Environ Int; 2019 Jan; 122():369-380. PubMed ID: 30503314
[TBL] [Abstract][Full Text] [Related]
12. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
[TBL] [Abstract][Full Text] [Related]
13. Circulating miRNAs Act as Diagnostic Biomarkers for Bladder Cancer in Urine.
Lin JT; Tsai KW
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924142
[TBL] [Abstract][Full Text] [Related]
14. MiR-188-5p and MiR-141-3p influence prognosis of bladder cancer and promote bladder cancer synergistically.
Yang X; Wang P
Pathol Res Pract; 2019 Nov; 215(11):152598. PubMed ID: 31562019
[TBL] [Abstract][Full Text] [Related]
15. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
[TBL] [Abstract][Full Text] [Related]
16. Expression of urinary miRNAs targeting NLRs inflammasomes in bladder cancer.
Mearini E; Poli G; Cochetti G; Boni A; Egidi MG; Brancorsini S
Onco Targets Ther; 2017; 10():2665-2673. PubMed ID: 28579804
[TBL] [Abstract][Full Text] [Related]
17. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ
Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772
[TBL] [Abstract][Full Text] [Related]
18. Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer.
Yonemori M; Seki N; Yoshino H; Matsushita R; Miyamoto K; Nakagawa M; Enokida H
Cancer Sci; 2016 Sep; 107(9):1233-42. PubMed ID: 27355528
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma.
Yerukala Sathipati S; Tsai MJ; Shukla SK; Ho SY; Liu Y; Beheshti A
Sci Rep; 2022 Mar; 12(1):4141. PubMed ID: 35264666
[TBL] [Abstract][Full Text] [Related]
20. Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
Du L; Jiang X; Duan W; Wang R; Wang L; Zheng G; Yan K; Wang L; Li J; Zhang X; Pan H; Yang Y; Wang C
Oncotarget; 2017 Jun; 8(25):40832-40842. PubMed ID: 28388561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
